Zelira Therapeutics is committed to world class science and evidence-based medicine

At Zelira Therapeutics we have been committed to research from the beginning and remain dedicated to building evidence for our products through clinical trials and ongoing real-world data collection in collaboration with specialists around the world.

These studies, both completed and ongoing, continue to build the evidence base for our products and inform the design of future clinical trials. We are committed to providing doctors and patients with the data and information they would expect from any pharmaceutical product. In this way we are accelerating our products along the pathway to regulatory approval and reducing the risks and costs of our clinical development program.

2016
2017
2018
2019
2020
2021
  Clinical Trial NO SVG
University of Western Australia
 
published
aus
2019 - 2020
Pharmacokinetic trial of ZTL-103 in high opioid
St Vincent’s Hospital Melbourne
manuscript submitted
aus
2019 - 2020
Open label observational study of HOPE in ASD patients
Emerald Clinics
 
in progress
aus
2021 - Present
Double-blind, randomised, placebo-controlled trial to evaluate ZTL-106 in treating pain from musculoskeletal injuries
La Trobe University - Sport and Exercise Medicine Research Centre in Victoria
 
in progress
aus
2020 - Present
  RWE NO SVG
Parkinson’s Foundation, New York, NY, USA
 
published
usa
2020
RWE to evaluate the effectiveness of medicinal cannabis to manage pain in high opioid users
Emerald Clinics
 
completed
aus
2020
Medicinal Cannabis registry of Autism patients
Children’s Hospital of Philadelphia, Pennsylvania
manuscript submitted
usa
2019 - 2020
2020
RWE to evaluate the long-term effectiveness of Zenivol ® (ZTL-101) in chronic insomnia
Emerald Clinics
 
in progress
aus
2021 - Present
  Pre-Clinical NO SVG
Anti-tumor effects of CBD and THC in pancreatic cancer
Curtin University WA
manuscript submitted
aus
2017 - 2020
2018 - 2020
CBD to prevent or restore BBB dysfunction in diabetes
Curtin University WA
 
in progress
aus
2019 - 2021
Cannabinoids for the treatment of childhood brain tumours
Telethon Kids Institute WA
 
completed
aus
2016 - 2020
Complutense University Madrid
 
published
spain
2016 - 2020
Formulation development of ZTL-106 for treating pain from musculoskeletal injuries (Levin)
Zelira Labs
 
completed
usa
2020

Start typing and press Enter to search

Shopping Cart